✦ LIBER ✦

Aromatization of androstenedione to estrogen by benign prostatic hyperplasia, prostate cancer and expressed prostatic secretions

✍ Scribed by Stone, N.N. ;Laudone, V.P. ;Fair, W.R. ;Fishman, J.

Publisher: Springer
Year: 1987
Tongue: English
Weight: 256 KB
Volume: 15
Category: Article
ISSN: 0300-5623
DOI: 10.1007/bf00254430

No coin nor oath required. For personal study only.

✦ Synopsis

Human prostatic tissue and expressed prostatic secretions (EPS) from patients with benign prostatic hyperplasia (BPH) and prostate cancer were incubated with (1 beta 3H) androstenedione. The extent of aromatization was determined by measuring the transfer of 3H from the 1 beta position into water. The amount of 3H2O recovered corresponds to the estrogens formed. Tissue from 5 patients with BPH yielded 2.13 (+/- 1.05) pmol/mg protein/h while the EPS from the same patients yielded 727 fmol/mg protein/h. In patients with prostate cancer the mean formation of estrogens was 388 fmol/mg protein/h (+/- 75). 4-hydroxy-androstenedione, an aromatase inhibitor, successfully inhibited aromatization in BPH and prostate cancer 53-98%.

📜 SIMILAR VOLUMES

Immunohistochemical analysis of Omi/HtrA

Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia

✍ Hu Xiaoyong; Chen Xiaochun; Ping Hao; Chen Zhaohui; Zeng Fuqing; Lu Gongcheng 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 Chinese ⚖ 420 KB

Differential expression of transforming

Differential expression of transforming growth factor-β1 and β3 as well asC-FOSmRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer

✍ V. W. Merz; A. M. Arnold; U. E. Studer 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 517 KB

Comparative study of stromal metalloprot

Comparative study of stromal metalloproteases expression in patients with benign hyperplasia and prostate cancer

✍ Safwan Escaff; Jesús M. Fernández; Luis O. González; Aurelio Suárez; Salomé Gonz 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 410 KB

CYP17 polymorphisms in relation to risks

CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: A population-based study in China

✍ M. Patricia Madigan; Yu-Tang Gao; Jie Deng; Ruth M. Pfeiffer; Bao-Li Chang; Siqu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 78 KB 👁 1 views

## Abstract Because androgens likely play a key role in prostate growth and prostate cancer development, variants of genes involved in androgen biosynthesis may be related to prostate cancer risk. The enzyme P450c17α, encoded by the __CYP17__ gene, catalyzes the conversion of progesterone and pregn

Panel VII: Scope of the problem. Indicat

Panel VII: Scope of the problem. Indications for treatment and assessment of benign prostatic hyperplasia and its relationship to cancer

✍ Winston Mebust; David Bostzvick; John Grayhack; Logan Holtgrewe; John Wasson; Ro 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

Perioperative prediction by MRI of prost

Perioperative prediction by MRI of prostate volume six to twelve months after laser-induced thermotherapy of benign prostatic hyperplasia

✍ Ullrich G. Mueller-Lisse; Markus Frimberger; Peter Schneede; Andreas F. Heuck; R 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

The purpose of this study was to predict prostate volume outcome 6-12 months after interstitial, laser-induced thermotherapy (LITT) for benign prostatic hyperplasia (BPH) on the basis of prostate magnetic resonance (MR) images obtained within 48 hours before and after LITT. Twenty patients (age, 64.